Evaluation of changes in Salivary Lactate Dehydrogenase Level for detection of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis Study

Niloufar Abedi, Laleh Maleki, Mohammad Javad Tarrahi, Saeedeh Khalesi

Abstract


Background: Research has examined the relationship between salivary lactate dehydrogenase (LDH) levels and head and neck squamous cell carcinoma (HNSCC) screening and prognosis. Due to biochemical changes in cancer cells and increased production of lactate products in the body. The present systematic review aims to evaluate the changes in salivary LDH levels in HNSCC patients. Methods: The present study is a systematic review and meta‑analysis. The data were collected by searching PubMed, Science Direct, Scopus, Web of Science, and Google Scholar from 2000 to 2021. The heterogeneity of the articles was analyzed using I2 and TAU2 . Results: After searching the databases, of 988 articles, 665 duplicated articles were excluded by adopting the inclusion and exclusion criteria. So, 25 articles were primarily selected to be reviewed and evaluated for quality. Finally, 19 articles were selected and analyzed according to the Newcastle–Ottawa checklist. A total of 642 HNSCC patients were reviewed. The meta‑analysis showed salivary LDH levels in the HNSCC group were higher than the control group (mean difference = 0.675, standard error = 0.058) (P < 0.001). Conclusions: As the research results showed, a significant correlation was observed between salivary LDH levels and HNSCCs. So, LDH can be employed as a valuable and minimally invasive biomarker in head and neck cancer screening and prevention.

Keywords


Head and neck squamous cell carcinoma; lactate dehydrogenase; saliva

Full Text:

PDF

References


Forastiere AA, Trotti A, Pfister DG, Grandis JR. Head and neck

cancer: Recent advances and new standards of care. Am J Clin

Oncol 2006;24:2603‑5.

Takenaka Y, Oya R, Aoki K, Hamaguchi H, Takemura K,

Nozawa M, et al. Pretreatment serum lactate dehydrogenase as

a prognostic indicator for oral cavity squamous cell carcinoma. Acta Otolaryngol 2017;138:433‑6.

Buch SC, Nazar‑Stewart V, Weissfeld JL, Romkes M.

Case‑control study of oral and oropharyngeal cancer in whites

and genetic variation in eight metabolic enzymes. Head Neck

;30:1139‑47.

Kumar M, Nanavati R, Modi TG, Dobariya C. Oral

cancer: Etiology and risk factors: A review. J Cancer Res Ther

;12:458‑63.

Anis R, Gaballah K. Oral cancer in the UAE: A multicenter,

retrospective study. Libyan J Med 2013;8:21782.

Lee KD, Lee HS, Jeon CH. Body fluid biomarkers for early

detection of head and neck squamous cell carcinomas. Anticancer

Res 2011;31:1161‑7.

Sivaramakrishnan M, Sivapathasundharam B, Jananni M.

Evaluation of lactate dehydrogenase enzyme activity in saliva

and serum of oral sub mucous fibrosis patients. J Oral Pathol

Med 2015;44:449‑52.

Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical

evaluation of diagnostic aids for the detection of oral cancer.

Oral Oncol 2008;44:10‑22.

Granchi C, Roy S, Giacomelli C, Macchia M, Tuccinardi T.

Discovery of N‑hydroxyindole‑based inhibitors of human lactate

IUBMB LIFE 908 LDHA in Cancerdehydrogenase isoform

A (LDH‑A) as starvation agents against cancer cells. J Med

Chem 2011;54:1599‑612.

El Mjiyad N, Caro‑Maldonado A, Ramírez‑Peinado S,

Muñoz‑Pinedo C. Sugar‑free approaches to cancer cell killing.

Oncogene 2011;30:253‑64.

Nagler RM, Lischinsky S, Diamond E, Klein I, Reznick AZ.

New insight into salivary lactate dehydrogenase of human

subjects. J Lab Clin Med 2001;137:363‑9.

Reznick AZ, Hershkovich O, Nagler RM. Saliva – A pivotal

player in the pathogenesis of oropharyngeal cancer. Br J Cancer

;91:111–8.

Scale NO. Wells GA, Shea B, O’Connell D, Peterson J,

Welch V, et al. The Newcastle‑Ottawa Scale (NOS) for

assessing the quality of nonrandomised studies in meta analyses

Available from: http://www.ohri.ca/programs/clinical_

epidemiology/oxford.asp.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A,

Petticrew M, et al. Preferred reporting items for svstematic

review and Meta‑analysis protocols (PRISMA‑P) 2015 statement.

Syst Rev 2015;4:1.

Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive

salivary analysis for oral cancer diagnosis. J Cancer Res Clin

Oncol 2007;133:613–7.

Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D,

Borovoi I, et al. Sa;ivary analysis of oral cancer biomarkers.

Brithish Journal of Cancer2009;101:94-98.

Merza KS, Alaaraji SB, Abdullah BH. Comparative

study on lactate dehydrogenase, alkaline phosphatase and

immunoglobulins in serum and saliva of acute leukemia and oral

squamous cell carcinoma patients. Iraqi J Sci 2010;51:262‑70.

Shetty SH, Chadha R, Babu S, Kumari S, Bhat S, Achalli S.

Salivary lactate dehydrogenase levels in oral leukoplakia and oral

squamous cell carcinoma: A biochemical and clinicopathological

study. J Can Res Ther 2012;8:S123‑5.

Joshi P, Golgire S. A study of salivary lactate dehydrogenase

isoenzyme levels in patients with oral leukoplakia and squamous

cell carcinoma by gel electrophoresis method. J Oral Maxillofac

Pathol 2014;18:S39‑44.

Dhivyalakshmi M, Maheswari TN. Expression of salivary

biomarkers – Alkaline phosphatase & lactate dehydrogenase in

oral leukoplakia. Int J Chem Tech Res 2014;6:2755‑9.

Patel S, Metgud R. Estimation of salivary lactate dehydrogenase

in oral leukoplakia and oral squamous cell carcinoma:

A biochemical study. J Cancer Res Ther 2015;11:119‑23.

Kadiyala SV. A study of salivary Lactate Dehydrogenase (LDH)

levels in oral cancer and oral submucosal fibrosis patients

amoung the normal individulas. J Pharm Sci Res 2015;7:455‑7.

Kallalli BN, Rawson K, Awati MA, Shivhare P. Lactate

dehydrogenase as a biomarker in oral cancer and oral submucous

fibrosis. J Oral Pathol Med 2016;11:1‑4.

Lokesh K, Kannabiran J, Rao MD. Salivary Lactate

Dehydrogenase (LDH)‑ A novel technique in oral cancer

detection and diagnosis. JCDR 2016;10:ZC34‑7.

D’Cruz AM, Pathiyil V. Histopathological differentiation of oral

squamous cell carcinoma and salivary lactate dehydrogenase:

A biochemical study. South Asian J Cancer 2015;4:58–60.

Rao K, Babu SG, Kumari S. Estimation of serum and salivary

lactate dehydrogenase levels among healthy individuals and

oral cancer patients A clinical and biochemical study. IJDSR

;2:31‑5.

Singh HP, Gandhi P, SH T. Estimation of salivary biomarkers in

patients with squamous cell carcinoma. Int J Clin Diagn Pathol

;1:29‑31.

Mohajertehran F, Ayatollahi H, Jafarian AH, Khazaeni K,

Soukhtanloo M, Shakeri MT, et al. Overexpression of lactate

dehydrogenase in the saliva and tissues of patients with head

and neck squamous cell carcinoma. Rep Biochem Mol Biol

;7:143‑9.

Mantri T, Thete SG, Male V, Yadav R, Grover I, Adsure GR,

et al. Study of the role of salivary lactate dehydrogenase

in habitual tobacco chewers, oral submucous fibrosis

and oral cancer as a biomarker. J Contemp Dent Pract

;20:970‑3.

Samlin SS, Divya K, Siva B, Sudarshan R, Vignesswary A,

Kumar MR. Salivary lactate dehydrogenase‑A biomarker of

potentially malignant and malignant diseases of oral cavity?.

AJDS 2019;2:1‑6.

Goyal G. Comparison of salivary and serum alkaline phosphates

level and lactate dehydrogenase levels in patients with tobacco

related oral lesions with healthy subjects‑A step towards early

diagnosis. APJCP 2020;21:983‑90.

Bel’skaya LV, Sarf EA, Solomatin DV, Kosenok VK. Diagnostic

and Prognostic value of salivary biochemical markers in oral

squamous cell carcinoma. Diagnostics 2020;10:818.

Gholizadeh N, Alipanahi Ramandi M, MotieeLangroudi M,

Jafari M, Sharouny H, Sheikhbahaei N. Serum and salivary

levels of lactate dehydrogenase in oral squamous cell carcinoma,

oral lichen planus and oral lichenoid reaction. BMC Oral Health

;20:314.

Todorovic T, Dozic I, Barrero MV, Ljuskovic B, Pejovic J,

Marjanovic M, et al. Salivary enzymes and periodontal disease.

Med Oral Patol Oral Cir Bucal 2006;11:E115‑9.

Neglar R, Lischinsky S, Diamond E, Drigues N, Klein I,

Reznick AZ. Effect of cigarette smoke on salivary proteins and

enzyme activities. Arch Biochem Biophse 2000;379:229‑36.

Varshitha A. Prevalence of Oral Cancer in India. J Pharm Sci

Res 2015;7:845‑8.

Byakodi R, Byakodi S, Hiremath S, Byakodi J, Adaki S,

Marathe K, et al. Oral cancer in India: An epidemiologic and

clinical review. J Community Health 2012;37:316‑9.

Amenabar JM, Da Silva BM, Punyadeera C. Salivary protein

biomarkers for head and neck cancer. Expert Rev Mol Diagn

;20:305‑13.